These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 8694809
21. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R. Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049 [Abstract] [Full Text] [Related]
22. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK, Medina D. Mol Carcinog; 1998 Jun 08; 22(2):128-43. PubMed ID: 9655257 [Abstract] [Full Text] [Related]
25. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y. EMBO J; 1996 Dec 16; 15(24):7060-9. PubMed ID: 9003781 [Abstract] [Full Text] [Related]
26. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Ohmori T, Yang JL, Price JO, Arteaga CL. Exp Cell Res; 1998 Dec 15; 245(2):350-9. PubMed ID: 9851876 [Abstract] [Full Text] [Related]
28. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1. Peterson SR, Gadbois DM, Bradbury EM, Kraemer PM. Cancer Res; 1995 Oct 15; 55(20):4651-7. PubMed ID: 7553644 [Abstract] [Full Text] [Related]
29. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells. Mann DJ, Higgins T, Jones NC, Rozengurt E. Oncogene; 1997 Apr 17; 14(15):1759-66. PubMed ID: 9150381 [Abstract] [Full Text] [Related]
30. Phosphorylation of E2F-1 by cyclin A-cdk2. Kitagawa M, Higashi H, Suzuki-Takahashi I, Segawa K, Hanks SK, Taya Y, Nishimura S, Okuyama A. Oncogene; 1995 Jan 19; 10(2):229-36. PubMed ID: 7838523 [Abstract] [Full Text] [Related]
31. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB. Kidney Int; 1997 Apr 19; 51(4):1228-36. PubMed ID: 9083291 [Abstract] [Full Text] [Related]
34. Fos proteins can act as negative regulators of cell growth independently of the fos transforming pathway. Balsalobre A, Jolicoeur P. Oncogene; 1995 Aug 03; 11(3):455-65. PubMed ID: 7630629 [Abstract] [Full Text] [Related]
37. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Wang Y, Prives C. Nature; 1995 Jul 06; 376(6535):88-91. PubMed ID: 7596441 [Abstract] [Full Text] [Related]
38. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity. Li W, Fan J, Bertino JR. Cancer Res; 2001 Mar 15; 61(6):2579-82. PubMed ID: 11289134 [Abstract] [Full Text] [Related]
39. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells. Zhang K, Kumar R. Biochem Biophys Res Commun; 1994 Apr 15; 200(1):522-8. PubMed ID: 8166726 [Abstract] [Full Text] [Related]
40. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. Zarkowska T, Mittnacht S. J Biol Chem; 1997 May 09; 272(19):12738-46. PubMed ID: 9139732 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]